Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved tags : Phase 2 save search
IntelGenx Receives Approval to Conduct ’MONTPARK’ Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson's Disease
Published: 2023-11-14 (Crawled : 12:30) - globenewswire.com
IGXT | $0.1639 -19.77% 400K
|
Manufacturing
|
| O: 7.74%
H: 1.85%
C: -0.96%
versafilm disease parkinson's approval montelukast trial phase 2
Atossa Therapeutics Receives Approval from Health Canada to Conduct Phase 2 EVANGELINE Clinical Trial in Canada
Published: 2023-07-20 (Crawled : 13:20) - globenewswire.com
ATOS | $1.505 1.01% 1.0% 1.9M
|
Health Technology
|
| O: 4.67%
H: 2.68%
C: 1.79%
health approval canada trial therapeutics phase 2
Nascent Submits Phase 2 Clinical Research Protocol to FDA for Review and Approval
Published: 2023-04-18 (Crawled : 15:20) - biospace.com/
NBIO | $0.0853 15.32% 140K
|
|
| O: -7.99%
H: 8.68%
C: 3.77%
fda approval review research phase 2
Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study
Published: 2023-02-01 (Crawled : 14:00) - biospace.com/
EDSA | $4.3 -3.7% -3.84% 5.1K
|
Health Technology
|
| O: -0.67%
H: 1.85%
C: -5.37%
biotech approval study phase 2
Skye Bioscience Obtains Central IRB Approval for Phase 2 Clinical Trial with SBI-100 Ophthalmic Emulsion
Published: 2023-01-27 (Crawled : 15:00) - biospace.com/
SKYE | $12.845 -8.45% -9.23% 110K
|
Transportation and Warehousing
|
| O: 3.57%
H: 10.0%
C: -1.72%
sbi-100 trial approval bioscience phase 2 ophthalmic emulsion
IN8bio Announces FDA Clearance to Initiate a Phase 2 Clinical Trial of INB-400 Gamma-Delta T Cells for Glioblastoma
Published: 2022-12-08 (Crawled : 13:20) - biospace.com/
INAB | $1.03 -0.96% -0.97% 150K
|
|
| O: 0.81%
H: 2.01%
C: -6.02%
inb-400 fda clearance trial phase 2 glioblastoma
MAIA Biotechnology, Inc. Announces HREC Approval in Australia for its THIO-101 Phase 2 Trial for NSCLC
Published: 2022-03-15 (Crawled : 13:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -3.03%
H: 3.21%
C: 3.21%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 3.07%
H: 0.0%
C: 0.0%
thio-101 phase 2 technology trial approval australia biotech iot
Algernon Pharmaceuticals Files for Clinical Trial and Ethics Approval for Phase 1 DMT Human Stroke Study
Published: 2022-01-19 (Crawled : 12:30) - globenewswire.com
AGNPF | $0.089 178.69% 75K
|
Health Technology
|
| O: 1.33%
H: 1.73%
C: -14.06%
als trial approval stroke phase 1 phase 2 phase 3
I-Mab Announces IND Approval from China NMPA for Phase 2 Clinical Trial of Enoblituzumab in Combination with Pembrolizumab in Solid Tumors
Published: 2021-12-27 (Crawled : 14:00) - biospace.com/
MGNX | $15.7 -3.27% -3.38% 520K
|
Health Technology
|
| O: -0.75%
H: 1.28%
C: -2.84%
IMAB | $1.805 0.28% 0.28% 110K
|
Health Technology
|
| O: -0.49%
H: 2.25%
C: -0.79%
phase 2 solid tumors trial approval china
Todos Medical CEO to Appear on Yahoo Finance Live! at 12:10PM EST with Akiko Fujita to Talk Pfizer’s Paxlovid Approval, Tollovir™ Phase 2 & COVID Testing
Published: 2021-12-23 (Crawled : 14:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M
|
Manufacturing
|
| O: -0.43%
H: 0.43%
C: -6.07%
phase 2 ceo approval covid covid test tollovir test
I-Mab Receives IND Approval for Phase 1 Clinical Trial of Bispecific Antibody TJ-CD4B in Solid Tumors in China
Published: 2021-12-15 (Crawled : 15:30) - biospace.com/
IMAB | $1.805 0.28% 0.28% 110K
|
Health Technology
|
| O: -11.41%
H: 8.08%
C: 7.32%
solid tumors trial approval phase 1 china antibody phase 2
PDS Biotech Provides Recruitment update for National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based CombinationInstitutional Review Board (IRB) approval has been obtained and clinical trial recruitment resumes
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
PDSB | $3.26 1.88% 1.84% 450K
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: 0.0%
phase 2 trial approval cancer biotech iot
Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress
Published: 2021-11-30 (Crawled : 13:00) - biospace.com/
CYBN | $0.355 -1.44% 3.5M
|
n/a
|
| O: 3.4%
H: 0.66%
C: -3.29%
new drug fda phase 2 drug trial approval covid
Oramed Announces Oravax's Oral COVID-19 Vaccine Has Received South African Approval to Initiate Phase 1 Trial
Published: 2021-10-29 (Crawled : 12:00) - biospace.com/
ORMP A | $2.375 1.06% 1.05% 41K
|
Health Technology
|
| O: 0.79%
H: 2.47%
C: -1.12%
covid phase 1 vaccine trial approval phase 2
I-Mab Announces IND Approval for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China
Published: 2021-10-18 (Crawled : 12:00) - prnewswire.com
IMAB | $1.805 0.28% 0.28% 110K
|
Health Technology
|
| O: -1.19%
H: 4.34%
C: 2.66%
phase 2 china therapy trial approval
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of Concern
Published: 2021-09-22 (Crawled : 12:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: -1.11%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.5%
H: 0.36%
C: -0.86%
ARCT 4 | $27.0 -3.33% -3.44% 270K
|
Health Technology
|
| O: 1.81%
H: 2.1%
C: -0.32%
phase 2 vaccine phase 3 approval sars-cov-2
Ayala Pharmaceuticals Presents Preliminary Clinical Data from the Ongoing Phase 2 ACCURACY Trial and Announces Pre-Clinical Proof of Concept Data for Enhanced Activity of AL101 in Combination with Approved Cancer Therapies in ACC
Published: 2021-09-16 (Crawled : 14:00) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.23%
H: 0.31%
C: -1.02%
AYLA | $0.5036 5.84% -0.7% 0
|
Health Technology
|
| O: 0.71%
H: 5.25%
C: -14.35%
phase 2 ongoing pre-clinical cancer proof of concept trial preclinical
RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval
Published: 2021-09-13 (Crawled : 12:00) - biospace.com/
RDHL | $0.415 -2.99% -3.08% 190K
|
Health Technology
|
| O: -0.74%
H: 0.45%
C: -7.98%
covid phase 2 biopharma ongoing phase 2/3 approval
Atossa Therapeutics Receives Approval from the Swedish Ethics Review Authority to Initiate a Phase 2 Clinical Study of Oral Endoxifen to Reduce Mammographic Breast Density in Sweden
Published: 2021-09-02 (Crawled : 14:00) - globenewswire.com
ATOS | $1.505 1.01% 1.0% 1.9M
|
Health Technology
|
| O: 0.27%
H: 14.33%
C: 0.8%
phase 2 approval authorized
Medivir receives regulatory approval from MHRA for phase 1/2a combination study with MIV-818
Published: 2021-08-31 (Crawled : 08:00) - prnewswire.com
IGMS | $7.95 3.25% 3.14% 690K
|
Health Technology
|
| O: 0.37%
H: 1.35%
C: -2.63%
phase 1 approval phase 2 phase 3
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.